These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37910041)

  • 21. Cellular toxicities of gadolinium-based contrast agents used in magnetic resonance imaging.
    Akbas E; Unal F; Yuzbasioglu D
    J Appl Toxicol; 2023 Jul; 43(7):958-972. PubMed ID: 36394883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compact Micellization: A Strategy for Ultrahigh T1 Magnetic Resonance Contrast with Gadolinium-Based Nanocrystals.
    Johnson NJ; He S; Nguyen Huu VA; Almutairi A
    ACS Nano; 2016 Sep; 10(9):8299-307. PubMed ID: 27588579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of Gadolinium Administration in Children.
    Elbeshlawi I; AbdelBaki MS
    Pediatr Neurol; 2018 Sep; 86():27-32. PubMed ID: 30390954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manganese-Based Contrast Agents as a Replacement for Gadolinium.
    Davis KA; Lazar B
    Radiol Technol; 2021 Sep; 93(1):36-45. PubMed ID: 34588277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Work in progress: potential oral and intravenous paramagnetic NMR contrast agents.
    Runge VM; Stewart RG; Clanton JA; Jones MM; Lukehart CM; Partain CL; James AE
    Radiology; 1983 Jun; 147(3):789-91. PubMed ID: 6844614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging.
    Gupta A; Caravan P; Price WS; Platas-Iglesias C; Gale EM
    Inorg Chem; 2020 May; 59(10):6648-6678. PubMed ID: 32367714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Staging and re-staging of soft tissue sarcoma using MRI. Usefulness of contrast media].
    Barile A; Caulo M; Zugaro L; Di Cesare E; Gallucci M; Masciocchi C
    Radiol Med; 2001 Jun; 101(6):444-55. PubMed ID: 11479441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadolinium-based bimodal probes to enhance T1-Weighted magnetic resonance/optical imaging.
    Yang CT; Hattiholi A; Selvan ST; Yan SX; Fang WW; Chandrasekharan P; Koteswaraiah P; Herold CJ; Gulyás B; Aw SE; He T; Ng DCE; Padmanabhan P
    Acta Biomater; 2020 Jul; 110():15-36. PubMed ID: 32335310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review.
    Iyad N; S Ahmad M; Alkhatib SG; Hjouj M
    Eur J Radiol Open; 2023 Dec; 11():100503. PubMed ID: 37456927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
    Low RN
    Top Magn Reson Imaging; 1998 Jun; 9(3):141-66. PubMed ID: 9621404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-assemblies of cationic mPEG brush block copolymers with gadolinium polyoxotungstate [Gd(W
    Ly J; Li Y; Vu MN; Moffat BA; Jack KS; Quinn JF; Whittaker MR; Davis TP
    Nanoscale; 2018 Apr; 10(15):7270-7280. PubMed ID: 29632934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of gadolinium-based contrast agents in neurological disorders.
    Golec W; Jakimów-Kostrzewa A; Mruk B; Jóźwiak S
    Neurol Neurochir Pol; 2020; 54(5):399-409. PubMed ID: 32955099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to Reduce the Use of Gadolinium-Based Contrast Agents for Abdominal MRI in Children.
    Anderson MA; Harrington SG; Kozak BM; Gee MS
    AJR Am J Roentgenol; 2020 May; 214(5):1054-1064. PubMed ID: 32097030
    [No Abstract]   [Full Text] [Related]  

  • 35. Preclinical evaluation of gadolinium (III) texaphyrin complex. A new paramagnetic contrast agent for magnetic resonance imaging.
    Young SW; Sidhu MK; Qing F; Muller HH; Neuder M; Zanassi G; Mody TD; Hemmi G; Dow W; Mutch JD
    Invest Radiol; 1994 Mar; 29(3):330-8. PubMed ID: 8175308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble paramagnetic chelates and stabilized colloidal particle solutions of iron oxides as contrast agents for magnetic resonance imaging.
    Tombach B; Reimer P
    Curr Med Chem; 2005; 12(23):2795-804. PubMed ID: 16305473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging.
    Parac-Vogt TN; Kimpe K; Laurent S; Piérart C; Elst LV; Muller RN; Binnemans K
    Eur Biophys J; 2006 Jan; 35(2):136-44. PubMed ID: 16217648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.
    Ersoy H; Rybicki FJ
    J Magn Reson Imaging; 2007 Nov; 26(5):1190-7. PubMed ID: 17969161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is it safe to use gadolinium-based contrast agents in MRI?
    Pullicino R; Das K
    J R Coll Physicians Edinb; 2017 Sep; 47(3):243-246. PubMed ID: 29465099
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.